The EPO published Medtronic's patent EP4049590A1 titled 'Device for Assessment of Brain Signals,' covering medical devices for brain signal monitoring and assessment. The patent application lists inventors Leonid M. Litvak, Steven M. Goetz, Christopher L. Pulliam, and Scott R. Stanslaski. IPC classifications include A61B 5/293 (brain signal analysis), A61B 5/00 (measurement/diagnosis), A61N 1/36 (neurostimulation), and G16H 20/40 (health informatics interventions). The patent is designated across all EU member states and additional European countries.

Medtronic and other entities developing brain-computer interface or neurostimulation technologies should review this patent to assess potential freedom-to-operate implications. Patent monitoring should be incorporated into compliance processes for companies operating in neurological medical device development. No immediate compliance actions are required as this is a patent publication rather than a regulatory requirement.